NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GenieBiome Limited

GenieBiome Limited

Private
Hong KongHealthcare & Life Scienceshttps://geniebiome.com/

Last Round

Series B

Nov 1, 2021

Company Overview

GenieBiome Limited is a biotechnology company that develops microbiome-based diagnostics and personalized therapeutic solutions for various diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

microbiome diagnosticsprecision medicinegut microbiomegut health supplementsmetagenomicsbioinformaticscolorectal cancer screeningmicrobiome testingd2c healthprobioticsnon-invasive diagnosticspersonalized nutritionbiotechclinical researchbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenieBiome Limited Comparables

Compare GenieBiome Limited with similar companies based on industry and business-model similarity.

GenieBiome Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMILI
78%
Viome Life Sciences, Inc.
77%
Floré
76%

GenieBiome Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 1, 2021
Series AAug 1, 2020

Key People

Founding team and executive leadership

Rachel Fan

Chief Executive Officer, GenieBiome Limited

Executive Team

GenieBiome Limited Investors

Notable investors and investment history

GenieBiome Limited investors
InvestorRounds
Beyond VenturesSeries A
The Chinese University of Hong KongSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2025

    Monthly visitors increased 162% MoM.

  • Nov 1, 2021

    Completed Series B funding round.

GenieBiome Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenieBiome Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenieBiome Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Employee Range25
Year Founded2020
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.